Delivery Order SPE2DB22D2007-SPE2DB24FH9KR
Award Date
2/8/24
Potential Completion Date
3/1/24
Potential Value
$44K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $33,122.52 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,563,692,912 units of DARZALEX FASPRO 1,800mg-30,000 15ml pharmaceuticals. The contract has a completion date of March 11, 2024 and was awarded on February 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00, which serves as the primary contract...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1,800mg-30,000 15ml vials of the pharmaceutical product DARZALEX FASPRO. The $100,151.40 order was awarded on September 27, 2021 with a completion date of October 19, 2021. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing pharmaceutical and medical supply products and services...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 100 mg/5 ml vials of the pharmaceutical product DARZALEX. The $1,556.44 contract has a completion date of March 19, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and has an existing indefinite delivery contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $11,040.84 firm fixed-price delivery order contract (SPE2DB22D3016|SPE2DB24FARH4) for the supply of DARZALEX FASPRO pharmaceutical products. This delivery order is under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as...
The U.S. Defense Logistics Agency (DLA) awarded a $35,881.26 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 30,000 units of the specialty drug DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has an ultimate completion date of January 27, 2025 and was awarded on January 3, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $44,163.36 firm fixed price delivery order is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceuticals. The contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA to provide a...
The Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $55,204.20 Firm Fixed Price contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a prescription drug product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the drug DARZALEX 400 MG/20 ML VIAL 20ML. The $15,511.12 contract has an ultimate completion date of April 29, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. The contract was awarded under a larger indefinite delivery contract (IDC) with a potential value of...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order (SPE2DB22D3016|SPE2DB24FARZ7) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,206,330 units of the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. The delivery order has a ceiling value of $11,040.84 and a period of performance through April 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $33,122.52 Delivery Order is for the provision of 4,564,490,081 units of the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has a firm fixed price, with a completion date of May 24, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the...